Brief: Onesource Specialty Pharma Says Co, Formycon AG Announce Strategic Manufacturing Partnership For Biosimilars
14/07/2026 05:33
BRIEF-Onesource Specialty Pharma Says Co, Formycon AG Announce Strategic Manufacturing Partnership For Biosimilars July 14 (Reuters) - Onesource Specialty Pharma Ltd ONEO.NS:
ONESOURCE SPECIALTY PHARMA - CO, FORMYCON AG ANNOUNCE STRATEGIC MANUFACTURING PARTNERSHIP FOR BIOSIMILARS
ONESOURCE SPECIALTY PHARMA - TO PROVIDE INTEGRATED DS AND DP MANUFACTURING FOR FORMYCON FROM BANGALORE FACILITY
Source text: ID:nBSE32HLv7
Further company coverage: ONEO.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Formycon AG
See all newsBrief: Formycon Says Fyb286 Expands Formycon Biosimilar Pipeline Targeting Niche Indication
Brief: FORMYCON AG - ENTERS COOPERATION AGREEMENTS WITH BIOCELYS AND SANTO BIOSIMILAR FOR BIOSIMILAR CANDIDATE
Brief: Formycon And Zydus Say FYB206 Becomes First Publicly Announced Keytruda Biosimilar Accepted For Review By FDA
Brief: Formycon AG - Clinical Development Of FYB206 Completed In July 2026
Formycon H1 revenue rises sharply on milestone payments, EBITDA loss narrows